​

Vera Therapeutics Ownership | Who Owns Vera Therapeutics?

OverviewForecastFinancialsChart

Vera Therapeutics Ownership Summary

Vera Therapeutics is owned by 108.55% institutional investors, 7.00% insiders. Avoro capital advisors is the largest institutional shareholder, holding 10.22% of VERA shares. T. Rowe Price New Horizons is the top mutual fund, with 2.67% of its assets in Vera Therapeutics shares.

VERA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockVera Therapeutics108.55%7.00%-15.55%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Avoro capital advisors5.61M10.22%$237.25M
Price t rowe associates inc /md/4.38M7.97%$185.11M
Blackrock funding, inc. /de3.94M7.18%$166.69M
Blackrock3.34M6.55%$120.76M
Fmr3.05M5.56%$129.12M
Vanguard group2.95M5.37%$124.74M
Sofinnova investments2.79M5.09%$118.16M
State street2.16M4.23%$77.99M
Commodore capital lp1.96M3.57%$82.83M
Holocene advisors, lp1.88M3.42%$79.33M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sofinnova investments2.79M8.61%$118.16M
Commodore capital lp1.96M6.07%$82.83M
Eversept partners, lp1.60M6.01%$67.66M
Altium capital management lp432.00K5.18%$18.27M
First light asset management1.26M5.10%$53.34M
Portman32.80K4.48%$1.19M
Logos global management lp875.00K4.33%$37.00M
Cutter capital management, lp212.70K3.69%$8.99M
Kynam capital management, lp1.46M3.64%$61.66M
First turn management464.81K3.52%$19.66M

Top Buyers

HolderShares% AssetsChange
Avoro capital advisors5.61M3.36%1.30M
Vestal point capital, lp1.07M2.70%1.07M
Lord, abbett1.15M0.15%727.66K
Federated hermes1.09M0.10%671.88K
Voya investment management695.09K0.03%591.68K

Top Sellers

HolderShares% AssetsChange
Morgan stanley305.44K0.00%-1.23M
Adage capital partners gp480.00K0.04%-894.00K
Polar capital---675.00K
Commodore capital lp1.96M6.07%-516.40K
Eversept partners, lp1.60M6.01%-450.14K

New Positions

HolderShares% AssetsChangeValue
Vestal point capital, lp1.07M2.70%1.07M$45.46M
Bioimpact capital257.79K1.55%257.79K$10.90M
Gw&k investment management186.60K0.07%186.60K$7.89M
Armistice capital178.28K0.10%178.28K$7.54M
Avidity partners management lp100.00K0.42%100.00K$4.23M

Sold Out

HolderChange
Parallel advisors-2.00
Pnc financial services group-5.00
Nelson, van denburg & campbell wealth management group-7.00
Capital performance advisors llp-11.00
Bessemer group-35.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024174-2.25%59,594,28011.34%1081.14%12126.04%35-30.00%
Sep 30, 20241781.71%53,475,7240.91%970.90%96-6.80%50-10.71%
Jun 30, 20241752.94%52,992,2973.28%1031.03%103-17.60%5686.67%
Mar 31, 202417075.26%51,310,37124.10%1001.07%125131.48%3042.86%
Dec 31, 20239712.79%41,345,6555.32%961.24%54-2131.25%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
T. Rowe Price New Horizons1.70M2.67%67.90K
US Small-Cap Growth II Equity Comp1.57M2.48%98.47K
Vanguard Total Stock Mkt Idx Inv1.50M2.35%3.15K
Fidelity Growth Compy Commingled Pl O1.16M2.11%-
Vanguard US Total Market Shares ETF1.33M2.09%-2.90K
T. Rowe Price Health Sciences1.20M1.89%23.80K
iShares Russell 2000 ETF1.20M1.88%-10.34K
Fidelity Growth Compy Commingled Pl S1.19M1.86%1.58K
SPDR® S&P Biotech ETF1.04M1.63%-11.15K
T. Rowe Price Integrated US SmCapGrEq989.96K1.56%534.29K

Recent Insider Transactions

DateNameRoleActivityValue
Feb 26, 2025Fordyce Marshall PRESIDENT AND CEOSell$31.15K
Feb 21, 2025Fordyce Marshall PRESIDENT AND CEOSell$296.03K
Feb 26, 2025Fordyce Marshall PRESIDENT AND CEOSell$219.73K
Jan 08, 2025Fordyce Marshall PRESIDENT AND CEOSell$78.75K
Jan 08, 2025Fordyce Marshall PRESIDENT AND CEOSell$237.49K

Insider Transactions Trends

DateBuySell
2025 Q1-6
2024 Q4-31
2024 Q3-21
2024 Q2-24
2024 Q117

VERA Ownership FAQ

Who Owns Vera Therapeutics?

Vera Therapeutics shareholders are primarily institutional investors at 108.55%, followed by 7.00% insiders and -15.55% retail investors. The average institutional ownership in Vera Therapeutics's industry, Biotech Stocks , is 68.48%, which Vera Therapeutics exceeds.

Who owns the most shares of Vera Therapeutics?

Vera Therapeutics’s largest shareholders are Avoro capital advisors (5.61M shares, 10.22%), Price t rowe associates inc /md/ (4.38M shares, 7.97%), and Blackrock funding, inc. /de (3.94M shares, 7.18%). Together, they hold 25.37% of Vera Therapeutics’s total shares outstanding.

Does Blackrock own Vera Therapeutics?

Yes, BlackRock owns 6.55% of Vera Therapeutics, totaling 3.34M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 120.76M$. In the last quarter, BlackRock increased its holdings by 18.71K shares, a 0.56% change.

Who is Vera Therapeutics’s biggest shareholder by percentage of total assets invested?

Sofinnova investments is Vera Therapeutics’s biggest shareholder by percentage of total assets invested, with 8.61% of its assets in 2.79M Vera Therapeutics shares, valued at 118.16M$.

Who is the top mutual fund holder of Vera Therapeutics shares?

T. Rowe Price New Horizons is the top mutual fund holder of Vera Therapeutics shares, with 2.67% of its total shares outstanding invested in 1.7M Vera Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools